Followers | 1870 |
Posts | 90275 |
Boards Moderated | 1 |
Alias Born | 09/02/2006 |
Tuesday, June 07, 2022 12:20:02 PM
Recent ADIL News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 09/28/2024 12:06:10 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/27/2024 09:20:46 PM
- Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 09/19/2024 12:30:00 PM
- Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 01:00:00 PM
- Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:13:57 PM
- Adial Pharmaceuticals Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04 • GlobeNewswire Inc. • 08/13/2024 01:00:00 PM
- Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 08/07/2024 01:00:00 PM
- Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044 • GlobeNewswire Inc. • 07/31/2024 12:30:00 PM
- Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 07/23/2024 12:30:00 PM
- Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 06/20/2024 12:30:00 PM
- Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 06/05/2024 12:30:00 PM
- Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th • GlobeNewswire Inc. • 05/29/2024 12:30:00 PM
- Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/15/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 09:03:18 PM
- Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office • GlobeNewswire Inc. • 04/22/2024 12:30:00 PM
- Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder • GlobeNewswire Inc. • 04/10/2024 12:30:00 PM
- Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/02/2024 12:30:00 PM
- Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds • GlobeNewswire Inc. • 03/02/2024 12:00:00 AM
- Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office • GlobeNewswire Inc. • 02/28/2024 02:30:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:22:13 PM
- Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office • GlobeNewswire Inc. • 02/13/2024 02:15:24 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/25/2024 09:30:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:15:23 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM